LMR Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

LMR Partners’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,000	Closed	-$116K	–	1233
2023 Q3	$116K	Buy	+1,000	New	+$107K	﹤0.01%	672

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

LMR Partners's HZNP Position: Q4 2023 in Review

LMR Partners sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 1,203,870 shares — an estimated $139M sold.

LMR Partners first reported a position in HZNP in Q2 2015 and held it in 10 quarters. The position peaked at $139M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

LMR Partners reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
LMR Partners sold 1,203,870 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $139M.
LMR Partners first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2015 and held it in 10 quarters.
LMR Partners's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $139M in Q3 2023.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on LMR Partners's 13F filing for Q4 2023, filed 14 Feb 2024.